2014
Prevalence of Guideline-Directed Medical Therapy Among Patients Receiving Cardiac Resynchronization Therapy Defibrillator Implantation in the National Cardiovascular Data Registry During the Years 2006 to 2008
Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, Masoudi FA, Varosy PD. Prevalence of Guideline-Directed Medical Therapy Among Patients Receiving Cardiac Resynchronization Therapy Defibrillator Implantation in the National Cardiovascular Data Registry During the Years 2006 to 2008. The American Journal Of Cardiology 2014, 113: 2052-2056. PMID: 24793671, PMCID: PMC4346333, DOI: 10.1016/j.amjcard.2014.03.049.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic beta-AntagonistsAged, 80 and overAngiotensin-Converting Enzyme InhibitorsCardiac Resynchronization TherapyCombined Modality TherapyDeath, Sudden, CardiacDefibrillators, ImplantableFemaleFollow-Up StudiesHeart FailureHumansMaleMiddle AgedPractice Guidelines as TopicPrevalenceRegistriesRetrospective StudiesRisk AssessmentSurvival AnalysisTreatment OutcomeUnited StatesVentricular Dysfunction, LeftConceptsGuideline-directed medical therapyCardiac resynchronization therapyImplantable Cardioverter-Defibrillator RegistryAngiotensin II receptor inhibitorΒ-blockersMedical therapyClass IReceptor inhibitorsNational Cardiovascular Data Registry Implantable Cardioverter Defibrillator RegistryCardiac resynchronization therapy defibrillator implantationLeft ventricular systolic dysfunctionSevere heart failure symptomsAngiotensin-converting enzyme inhibitorNational Cardiovascular Data RegistryClass I indicationsCRT-D implantationHeart failure symptomsVentricular systolic dysfunctionProportion of patientsSelection of patientsReal-world patientsAngiotensin-converting enzymePrevalence of guidelinesContemporaneous guidelinesQuality improvement targets
2011
ACCF/AHA Methodology for the Development of Quality Measures for Cardiovascular Technology A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures
Bonow RO, Douglas PS, Buxton AE, Cohen DJ, Curtis JP, DeLong E, Drozda JP, Ferguson TB, Heidenreich PA, Hendel RC, Masoudi FA, Peterson ED, Taylor AJ. ACCF/AHA Methodology for the Development of Quality Measures for Cardiovascular Technology A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures. Journal Of The American College Of Cardiology 2011, 58: 1517-1538. PMID: 21880456, DOI: 10.1016/j.jacc.2011.07.007.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAmerican Heart AssociationGuideline recommendationsCardiovascular careAmerican CollegeAmerican Heart Association Task ForceACCF/AHA guidelinesClass IAppropriate use criteriaCardiology Foundation/American Heart Association Task ForceCardiovascular technologyTask ForceUse measuresPublic reportingParameters of careStrength of evidenceAHA guidelinesHeart AssociationSafety measuresCardiovascular diseaseCardiology FoundationSpecific indicationsA ReportPatient safetyUse criteriaEvaluation of qualityACCF/AHA Methodology for the Development of Quality Measures for Cardiovascular Technology
Bonow RO, Douglas PS, Buxton AE, Cohen DJ, Curtis JP, Delong E, Drozda JP, Ferguson TB, Heidenreich PA, Hendel RC, Masoudi FA, Peterson ED, Taylor AJ. ACCF/AHA Methodology for the Development of Quality Measures for Cardiovascular Technology. Circulation 2011, 124: 1483-1502. PMID: 21875906, DOI: 10.1161/cir.0b013e31822935fc.Peer-Reviewed Original ResearchConceptsAmerican Heart AssociationGuideline recommendationsCardiovascular careACCF/AHA guidelinesCardiovascular technologyClass IAppropriate use criteriaUse measuresTask ForcePublic reportingParameters of careStrength of evidenceAHA guidelinesHeart AssociationSafety measuresCardiovascular diseaseCardiology FoundationAmerican CollegeSpecific indicationsPatient safetyUse criteriaEvaluation of qualityCardiac imagingClinical topicsHealthcare quality